Imperial Innovations, Novartis deal

Imperial Innovations granted Novartis' Novartis Vaccines and Diagnostics Inc. subsidiary exclusive, worldwide rights to IP covering an undisclosed preclinical vaccine against meningitis B. Imperial re...